The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s non-steroidal anti-inflammatory drugs market report forecasts the non-steroidal anti-inflammatory drugs market size to grow to $24.88 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Non-Steroidal Anti-Inflammatory Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast
The global non-steroidal anti-inflammatory drugs market is expected to grow from $18.27 billion in 2022 to $19.57 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The non-steroidal anti-inflammatory drugs market size is expected to grow to $24.88 billion in 2027 at a CAGR of 6.2%.

North America held the largest non-steroidal anti-inflammatory drugs market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Non-Steroidal Anti-Inflammatory Drugs Market Driver ­– Growth In The Incidence Of Chronic Pain
For instance, in April 2022, according to the report of the CDC (Centers for Disease Control and Prevention), a US-based government agency, chronic pain was frequently caused by arthritis that affects millions of people in the US. Approximately one in four adults with arthritis among 15 million people are experiencing severe joint pain related to arthritis. Therefore, the growing incidence of chronic pain is driving the growth of the non-steroidal anti-inflammatory drugs market.

Request for A Sample Of The Global Non-Steroidal Anti-Inflammatory Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Key Non-Steroidal Anti-Inflammatory Drugs Market Trend – Product Innovation
Major companies operating in the non-steroidal anti-inflammatory drugs market are concentrating on creating new technology solutions. For instance, in May 2021, Ono and Seikagaku, a Japan-based company operating in non-steroidal anti-inflammatory drugs, launched JOYCLU, a 30 mg intra-articular injection. It is a formulation that uses Seikagaku’s proprietary technology to chemically bind hyaluronic acid with diclofenac (an anti-inflammatory medication). It is intended to release diclofenac in the joint via hydrolysis, is licenced for the treatment of osteoarthritis, and is predicted to relieve symptoms after a four-week intra-articular injection. It is administered directly into the joint cavity as an injection, resulting in low systemic exposure to diclofenac and a low risk of a systemic adverse drug reaction. It is the first ethical drug in Japan with the indication of osteoarthritis of the hip joint among joint function improvement agents.

Non-Steroidal Anti-Inflammatory Drugs Market Segment
1) By Route of Administration: Oral, Topical, Other Route of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, and Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Non-Steroidal Anti-Inflammatory Drugs Market Major Players and Strategies
Major players in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd., Merck & Co Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Sanofi S.A., AstraZeneca, Horizon Therapeutics plc, Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, F. Hoffmann-La Roche Ltd., Mylan N.V., and Novartis AG.

In March 2022, Pfizer, a US-based company engaged in pharmaceuticals and biotechnology, acquired Arena Pharmaceuticals for an undisclosed amount. With this acquisition, Arena Pharmaceuticals brings to Pfizer a diverse pipeline of development-stage therapeutic candidates in dermatology, gastroenterology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a variety of immuno-inflammatory diseases such as Crohn’s disease, ulcerative colitis, atopic dermatitis, eosinophilic esophagitis, and alopecia. Arena Pharmaceuticals is a US-based company operating in the field of non-steroidal anti-inflammatory drugs.

The Non-Steroidal Anti-Inflammatory Drugs Global Market Report 2023 covers regional data on non-steroidal anti-inflammatory drugs market size, non-steroidal anti-inflammatory drugs market trends and drivers, opportunities, strategies, and non-steroidal anti-inflammatory drugs market competitor analysis. The countries covered in the non-steroidal anti-inflammatory drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Non-steroidal anti-inflammatory drugs are medications that reduce inflammation and lower a fever. They are used to treat headaches, sprains and strains, painful periods, colds and flu, arthritis, and other long-term pain conditions, and to reduce inflammation, relieve pain, and bring down a high temperature.

View More Reports Related To The Non-Steroidal Anti-Inflammatory Drugs Market –
Corticosteroids Global Market Report 2023
Inflammatory Bowel Disease Treatment Global Market Report 2023
Acne Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: